Search by Drug Name or NDC
NDC 53002-1725-01 Balziva Details
Balziva
Balziva is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is .
Product Information
NDC | 53002-1725 |
---|---|
Product ID | 53002-1725_cae7e7c3-3121-4132-ab99-c5a121bb7d94 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Balziva |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Norethindrone and Ethinyl Estradiol |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | KIT |
Route | n/a |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | RPK Pharmaceuticals, Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA076238 |
Listing Certified Through | 2024-12-31 |
Package
NDC 53002-1725-01 (53002172501)
NDC Package Code | 53002-1725-1 |
---|---|
Billing NDC | 53002172501 |
Package | 1 KIT in 1 BLISTER PACK (53002-1725-1) |
Marketing Start Date | 2018-10-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |